Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study

The Journal of Headache and Pain

Poster Presentation

DC Buse¹  AN Manack²  C Cunanan²  S Kori³  ML Reed⁴  D Serrano⁴ 

[1] Albert Einstein College of Medicine, Kragujevac, USA;Allergan Inc., Kragujevac, USA;MAP Pharmaceuticals, Kragujevac, USA;Vedanta Research, Kragujevac, USA;

关键词: Migraine;    Barbiturate;    Change Score;    Triptan;    Migraine Prevalence;   

DOI  :  10.1186/1129-2377-14-S1-P212

来源: Springer

【 授权许可】

Unknown   
© Buse et al; licensee Springer. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.